Ning Hou
Impact in
- Drug Discovery top 10%
- Cancer Research top 5%
- MicroRNA in disease regulation
Papers in
-
- Cardiac Fibrosis and Remodeling 20
- Cardiovascular Function and Risk Factors 9
-
- Traditional Chinese Medicine Analysis 8
- Co-authors
- Jiandong Luo (21 shared papers)Xiao Yi Yang (4 shared papers)Yilang Li (9 shared papers)Youyi Zhang (4 shared papers)Zhenhua Li (5 shared papers)Cheng-Feng Luo (10 shared papers)Faqian Li (5 shared papers)Xiaoqing Chen (5 shared papers)
- Journals
- Frontiers in Pharmacology (4 papers)Clinical and Experimental Pharmacology and Physiology (3 papers)International Journal of Biological Sciences (3 papers)Cardiovascular Research (2 papers)Circulation Research (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ning Hou
62 papers receiving 2k citations
Peers
Comparison fields: 5 of 93
- Drug Discovery 9
- Cancer Research 326
- Cardiology and Cardiovascular Medicine 465
- Molecular Biology 702
- Complementary and alternative medicine 102
Countries citing papers authored by Ning Hou
This map shows the geographic impact of Ning Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Hou more than expected).
Fields of papers citing papers by Ning Hou
This network shows the impact of papers produced by Ning Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Hou. The network helps show where Ning Hou may publish in the future.
Co-authors
The 25 scholars most cited alongside Ning Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 180 | |
| 2 | 2015 | 166 | |
| 3 | 2005 | 126 | |
| 4 | 2020 | 108 | |
| 5 | 2019 | 106 | |
| 6 | 2019 | 79 | |
| 7 | 2018 | 75 | |
| 8 | 2011 | 66 | |
| 9 | 2020 | 64 | |
| 10 | 2016 | 62 | |
| 11 | 2020 | 59 | |
| 12 | 2020 | 52 | |
| 13 | 2016 | 51 | |
| 14 | 2017 | 46 | |
| 15 | 2018 | 42 | |
| 16 | 2012 | 37 | |
| 17 | 2012 | 36 | |
| 18 | 2019 | 34 | |
| 19 | 2019 | 34 | |
| 20 | 2013 | 33 |
About Ning Hou
Ning Hou is a scholar working on Cardiology and Cardiovascular Medicine, Complementary and alternative medicine, Molecular Biology, Cell Biology and Cancer Research, having authored 65 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (20 papers), Cardiovascular Function and Risk Factors (9 papers), Traditional Chinese Medicine Analysis (8 papers), Autophagy in Disease and Therapy (6 papers), Genomics, phytochemicals, and oxidative stress (5 papers), Peroxisome Proliferator-Activated Receptors (5 papers), Hippo pathway signaling and YAP/TAZ (4 papers) and Wnt/β-catenin signaling in development and cancer (3 papers). The work is most often cited by research in Drug Discovery (9 citations), Cancer Research (326 citations), Cardiology and Cardiovascular Medicine (465 citations), Molecular Biology (702 citations) and Complementary and alternative medicine (102 citations). Ning Hou has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jiandong Luo, Xiao Yi Yang, Yilang Li, Youyi Zhang, Zhenhua Li, Cheng-Feng Luo, Faqian Li, Xiaoqing Chen, Xuan Cheng and Wenchang Yuan. Their work appears in journals such as Frontiers in Pharmacology, Clinical and Experimental Pharmacology and Physiology, International Journal of Biological Sciences, Cardiovascular Research and Circulation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.